Dravet syndrome: A quick transition guide for the adult neurologist

Danielle M Andrade1, Anne T Berg2, Veronica Hood3

  • 1Adult Epilepsy Genetics Program, Division of Neurology, Krembil Brain Institute, Toronto Western Hospital, University of Toronto, Toronto, Canada.

Epilepsy Research
|October 8, 2021
PubMed

Insights

Transitioning Dravet syndrome (DS) patients to adult care is challenging. This guide aids the move from pediatric to adult healthcare systems, improving care for young adults with DS.

Area of Science:

  • Neurology
  • Pediatrics
  • Healthcare Transition

Background:

  • Dravet syndrome (DS) is often viewed as a pediatric condition, leading to suboptimal care for adults within adult healthcare systems.
  • The transition from family-centered pediatric care to patient-centered adult healthcare presents significant challenges for young adults with DS.

Purpose of the Study:

  • To develop a practical guide for facilitating the transition of care for patients with Dravet syndrome from pediatric to adult healthcare systems.
  • To address the specific needs and challenges faced by adults with DS as they navigate adult healthcare.

Main Methods:

  • Expert consensus from Dravet syndrome specialists identified key barriers to adult care.
  • A comprehensive literature review informed the development of a 2-page transition summary guide.

Main Results:

  • The guide details DS diagnosis, clinical manifestations (including age-related differences in seizures), and natural history (intellectual disability, behavior, motor disorders, dysautonomia).
  • It covers optimal treatments (e.g., stiripentol, fenfluramine), emergency seizure management, trigger avoidance, preventive measures, and vaccinations for adults with DS.

Conclusions:

  • Many young adults with DS remain under the care of pediatric neurologists, highlighting the need for improved adult care integration.
  • This transition guide aims to support families and adult healthcare providers in managing Dravet syndrome in adult patients, ensuring continuity and quality of care.
Abstract

Related Concept Videos

Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
863
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
43